Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ

Business

FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS/Arnd Wiegmann/File Photo

(Reuters) – Swiss drugmaker Novartis AG (NOVN.S) is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co (MDCO.O) for about $7 billion, the Wall Street Journal reported on Saturday.

The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the matter.

Neither Novartis nor The Medicines Co were immediately available for comment on Saturday.

Reporting by Kanishka Singh in Bengaluru; editing by Jonathan Oatis

Products You May Like

Articles You May Like

Energy bills expected to hit £4,200 in January, according to dire new forecast
Liz Truss ‘misinterpreted’ over ‘no handouts’ remark, her supporters say
Lightning strikes oil facility – 17 missing and 77 hurt, with flames raging out of control
Next swoops for big stake in struggling lifestyle retailer Joules
Russian journalist who protested Ukraine war live on TV and held banner saying ‘Putin is a killer’ has home raided

Leave a Reply

Your email address will not be published.